COMMUNIQUÉS West-GlobeNewswire

NKGen Biotech To Present on the Use of Troculeucel for Alzheimer’s and Parkinson’s Disease at the 7th China International Biotechnology Conference & Exhibition
14/04/2025
SANTA ANA, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative [...]
HealthLynked Welcomes Anthony Scuilla as Sales Consultant to Drive Strategic Partnerships with Insurance Providers
14/04/2025
NAPLES, Fla., April 14, 2025 (GLOBE NEWSWIRE) -- via IBN -- HealthLynked Corp. ( OTCQB: HLYK ), a leader in healthcare technology innovation, is proud to announce the appointment of Anthony "Tony" Scuilla as a strategic [...]
Fate Therapeutics Receives Regenerative Medicine Advanced Therapy (RMAT) Designation from FDA for FT819 to Treat Moderate to Severe Systemic Lupus Erythematosus (SLE)
14/04/2025
– Recognizes potential of off-the-shelf CAR T-cell therapy to address significant unmet need and enables increased dialogue with FDA throughout the development process – RMAT review by FDA included initial clinical [...]
Coherus Completes Strategic Transformation with Successful Divestiture of UDENYCA® Franchise
14/04/2025
– $250 million post-close cash balance extends cash runway over two years into 2027, funding pipeline development through key data catalysts – – Coherus to focus exclusively on its innovative novel oncology programs [...]
Certara Reports Preliminary First Quarter 2025 Financial Results; Announces $100 Million Share Repurchase Authorization
14/04/2025
Reiterates Full-Year 2025 Guidance Arsenal Capital Partners agrees to a one-year lock-up RADNOR, Pa., April 14, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, [...]
Lachine Hospital Foundation Gala raises $406,500 to support the modernization of Lachine Hospital
14/04/2025
The Lachine Hospital Foundation’s signature Gala raised an incredible $406,500 to support the Dream Big: Lachine Hospital campaign, a successful collaboration between the Lachine Hospital Foundation and the MUHC [...]
Le Gala de la Fondation de l'Hôpital de Lachine amasse 406 500 $ pour soutenir la modernisation de l'Hôpital de Lachine
14/04/2025
Le Gala signature de la Fondation de l'Hôpital de Lachine a permis de recueillir un montant impressionnant de 406 500 $ pour soutenir la campagne Oser Rêver : Hôpital de Lachine , une collaboration réussie entre la [...]
Catheter Precision, Inc. Receives Notice of First Patent Allowance in the US for LockeT Product Line
14/04/2025
Fort Mill, S.C., April 14, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac [...]
SBC Medical Group Holdings, Inc. Purchases 5 BTC
14/04/2025
IRVINE,Calif., April 14, 2025 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings (Headquarters: California, USA; CEO: Yoshiyuki Aikawa) hereby announces that, based on the announcement of a decision to purchase Bitcoin (BTC [...]
Inhibikase Therapeutics Announces Appointment of David McIntyre as Chief Financial Officer
14/04/2025
BOSTON and ATLANTA, April 14, 2025 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company innovating small molecule kinase inhibitor [...]
Elutia Confirms No Material Impact from Global Tariffs
14/04/2025
SILVER SPRING, Md., April 14, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix products, today confirmed that the ongoing global tariff environment has [...]
XOMA Royalty Completes Sale of Kinnate Pipeline Assets
14/04/2025
XOMA Royalty sold the remaining Kinnate pipeline assets for a total of up to $270 million in upfront and milestone payments, plus royalties on commercial sales at rates ranging from low single digits to mid-teens [...]
Relmada Therapeutics To Present NDV-01 Data at AUA2025
14/04/2025
Data to be presented on Monday, April 28, 2025 CORAL GABLES, Fla., April 14, 2025 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada”, “the Company”), a clinical-stage biotechnology company, today [...]
Avicanna Reports Full Year 2024 Audited Financial Statement
14/04/2025
2024 Revenue of $25.5M, a 52% increase from 2023 Consolidated Gross Margins of 51%, Gross Profits of $12.9M, a 94% increase from 2023 TORONTO, April 14, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or the “ [...]
SynOx Therapeutics Receives Fast Track Designation from U.S. Food and Drug Administration for Emactuzumab for Tenosynovial Giant Cell Tumours (TGCT)
14/04/2025
DUBLIN, Ireland and OXFORD, United Kingdom, April 14, 2025 (GLOBE NEWSWIRE) -- SynOx Therapeutics Limited (“SynOx”), a late-stage clinical biopharmaceutical company developing of emactuzumab for Tenosynovial Giant Cell [...]
Lifecore Biomedical Appoints Thomas D. Salus as Chief Legal and Administration Officer
14/04/2025
Mr. Salus Brings More than 30 Years of Broad-Based Legal and Management Expertise Highlighted by Extensive Experience within Life Sciences Industry Significantly Elevates Lifecore’s Capabilities Across Corporate [...]
10 Barrel Brewing Co. and Scout Campers Unveil Camp Coldie: The Ultimate Adventure Beer
14/04/2025
BEND, Ore., April 14, 2025 (GLOBE NEWSWIRE) -- 10 Barrel Brewing , a Tilray Brands, Inc., craft beer brand (NASDAQ: TLRY and TSX: TLRY), introduces Camp Coldie , 10 Barrel Brewing Co.’s highly-crushable new 5% IPA [...]
Castle Biosciences to Release First Quarter 2025 Financial Results and Host Conference Call on Monday, May 5, 2025
14/04/2025
FRIENDSWOOD, Texas, April 14, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it will release its [...]
Soleno Therapeutics Announces VYKAT(TM) XR Launch
14/04/2025
First prescriptions delivered to individuals with PWS REDWOOD CITY, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics [...]

Pages